QR-koda

Pneumonitis in Patients Receiving Thoracic Radiotherapy and Osimertinib: A Multi-Institutional Study

Introduction: Thoracic radiotherapy (TRT) is increasingly used in patients receiving osimertinib for advanced NSCLC, and the risk of pneumonitis is not established. We investigated the risk of pneumonitis and potential risk factors in this population. Methods: We performed a multi-institutional retr...

Olles dieđut

Furkejuvvon:
Váldodahkkit: Leou Ismael Banla, MD, PhD, Alice Tzeng, MD, PhD, John P. Baillieul, Melin J. Kandekhar, MD, PhD, Kelly J. Fitzgerald, MD, PhD, Jaclyn LoPiccolo, MD, PhD, Holly A. Poitras, Daniel E. Soto, MD, Julia K. Rotow, MD, Lisa Singer, MD, PhD, Henning Willers, MD, David E. Kozono, MD, PhD, Pasi A. Janne, MD, PhD, Raymond H. Mak, MD, Zofia Piotrowska, MD, Florence K. Keane, MD, Benjamin H. Kann, MD
Materiálatiipa: Artigo
Giella:Inglês
Almmustuhtton: Elsevier 2023-10-01
Ráidu:JTO Clinical and Research Reports
Fáttát:
Pneumonitis
Osimertinib
Radiation
Lung cancer
Tyrosine kinase inhibitors
Liŋkkat:http://www.sciencedirect.com/science/article/pii/S2666364323001029
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

Geahča maid